|
NIN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.2811000005275E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44939999949345E-07 |
| Normal-vs-Stage2 |
1.620480E-02 |
| Normal-vs-Stage3 |
1.017630E-03 |
| Normal-vs-Stage4 |
2.257800E-03 |
| Stage1-vs-Stage2 |
5.785800E-01 |
| Stage1-vs-Stage3 |
4.076400E-01 |
| Stage1-vs-Stage4 |
5.696400E-01 |
| Stage2-vs-Stage3 |
9.587600E-01 |
| Stage2-vs-Stage4 |
9.501800E-01 |
| Stage3-vs-Stage4 |
8.907000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60190000042526E-07 |
| Normal-vs-AfricanAmerican |
2.040300E-02 |
| Normal-vs-Asian |
4.510300E-02 |
| Caucasian-vs-AfricanAmerican |
5.265800E-01 |
| Caucasian-vs-Asian |
3.342600E-01 |
| AfricanAmerican-vs-Asian |
2.270600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35370000004165E-06 |
| Normal-vs-Female |
4.96439999997378E-07 |
| Male-vs-Female |
4.111000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.356500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.39050000017116E-07 |
| Normal-vs-Age(61-80Yrs) |
2.0198999999943E-05 |
| Normal-vs-Age(81-100Yrs) |
5.103600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.162400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.985400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.229200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.297200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.130800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.952800E-04 |
| Normal-vs-Grade 2 |
1.49849999964147E-07 |
| Normal-vs-Grade 3 |
4.244300E-04 |
| Normal-vs-Grade 4 |
2.718700E-03 |
| Grade 1-vs-Grade 2 |
5.144100E-02 |
| Grade 1-vs-Grade 3 |
3.075200E-03 |
| Grade 1-vs-Grade 4 |
3.795700E-02 |
| Grade 2-vs-Grade 3 |
5.476200E-02 |
| Grade 2-vs-Grade 4 |
5.744600E-01 |
| Grade 3-vs-Grade 4 |
4.250800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.14729997408625E-09 |
| Normal-vs-ccB subtype |
7.371500E-04 |
| ccA subtype-vs-ccB subtype |
5.591900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.83890000022325E-07 |
| Normal-vs-N1 |
1.118210E-01 |
| N0-vs-N1 |
9.681800E-01 |
|
|
